Sudden Onset of Brain Metastasis despite the Use of Vemurafenib for Another Metastatic Lesion in Malignant Melanoma Patients

Publisher： Karger

E-ISSN： 1662-6575|10|1|290-295

ISSN： 1662-6575

Source： Case Reports in Oncology, Vol.10, Iss.1, 2017-04, pp. : 290-295

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cutaneous toxicities associated with vemurafenib therapy in 107 patients with BRAF V600E mutation‐positive metastatic melanoma, including recognition and management of rare presentations

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 173, Iss. 4, 2015-10 ,pp. : 1024-1031

John Wiley & Sons Inc

Access to resources Recommend Favorite

Metastatic Melanoma: Treatment and Survival in the US after the Introduction of Ipilimumab and Vemurafenib

By  

Oncology Research and Treatment, Vol. 40, Iss. 4, 2017-03 ,pp. : 174-183

Karger

Access to resources Recommend Favorite

Prognostic Factors in Metastatic Malignant Melanoma

By  

Oncology, Vol. 55, Iss. 1, 1997-12 ,pp. : 59-64

Karger

Access to resources Recommend Favorite

Survival and Prognostic Factors in Patients with Brain Metastases from Malignant Melanoma

By  

Oncology Research and Treatment, Vol. 27, Iss. 2, 2004-05 ,pp. : 145-149

Karger

Access to resources Recommend Favorite

Linac Radiosurgery for Brain Metastasis of Melanoma

By  

Stereotactic and Functional Neurosurgery, Vol. 79, Iss. 3-4, 2003-07 ,pp. : 245-255

Karger

Access to resources Recommend Favorite